Meet the 38-year-old who's key to Amazon's health ambitions
Hello,
Today in healthcare news: Moderna plans to test its vaccine in kids in 2020, GoodRx surged in its first day of trading, and meet the 38-year-old tech lead at Amazon Care.
Plus: Kimberly Leonard has a comprehensive look at everything that could go wrong in a coronavirus-vaccine handoff if Biden ousts Trump in November.
And a lil' news from me: Healthcare startup Bind, known for its on-demand plans, is getting into the insurance business, starting with fully-insured employers in Florida. It has its eyes on the individual exchanges next.
Drugmakers still haven't started testing their coronavirus vaccines in children, putting kids at the end of the line for a potential shot
Ongoing clinical trials are testing the top coronavirus vaccine candidates only in adults.
Some experts are worried about the timeline for making a shot available to kids.
Read the full story from Andrew Dunn here>>
Discount prescription drug startup GoodRx surged 53% in its first day of trading. Here's what you need to know.
GoodRx, a discount-prescription startup, went public on Wednesday at $33 per share and surged to close at $50.50.
The stock closed with a market cap of $19.4 billion.
Read the full recap of GoodRx's first day of trading from Megan Hernbroth here>>
How a 38-year-old who taught himself health technology is shaping a key part of Amazon's plans to transform healthcare
Amazon Care, the company's health clinic, is expanding to cover all Washington employees.
Business Insider spoke with one of its tech leaders, Erik Cardenas, about Amazon Care's strategy.
Read the full story from Blake Dodge here>>
More stories we're reading:
2 top execs at Microsoft lay out how it's using the cloud to take on Google and Amazon as tech giants push deeper into the $3.6 trillion healthcare industry (Business Insider)
The UK is expecting to run trials in January testing vaccines on volunteers that have been intentionally infected with COVID-19 (Financial Times)
GoodRx's co-CEOs made millions when the company went public. Here's how their compensation compares to leaders at CVS, Walgreens, and Teladoc.(Business Insider)
Demand for lab space is booming, and real-estate giant JLL just hired a new life-sciences expert to lean into the opportunity (Business Insider)
Reopening colleges likely fueled COVID-19, according to a study (The Wall Street Journal)
I'll be back with a weekly wrap-up of healthcare news tomorrow (what a week!) See you then.
Don't forget to subscribe to our newsletter here!
- Lydia
Read the original article on Business Insider